SIRT1 and myeloid sarcoma: Interestingly, increasing evidence suggests that the activation of the AMPK/SIRT1 pathway might regulate MS-induced demyelination, oxidative stress, and neuroinflammation (Paintlia et al. 2013; Elbaz et al. 2018; Dziedzic et al. 2020).